Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLEAN+
NCT07696793Phase 4Recruiting
- Sponsor
- Fundació Clínic per a la Recerca Biomèdica
- Start
- May 2026
- Primary completion
- May 2028
- Countries
- 1
01
Overview
Phase 4, randomised trial of polyethylene glycol + citrate + simethicone in colorectal cancer (CRC) (2 arms), sponsored by Fundació Clínic per a la Recerca Biomèdica. Primary endpoint: Adenoma detection rate at 2 weeks. Started May 2026; status: recruiting.
02
Drugs
polyethylene glycol + citrate + simethicone
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT07696793.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07696793.